Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors

The synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and this modification led to enhanced p38...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2008-03, Vol.18 (6), p.2222-2226
Hauptverfasser: Chen, Meng-Hsin, Fitzgerald, Patricia, Singh, Suresh B., O’Neill, Edward A., Schwartz, Cheryl D., Thompson, Chris M., O’Keefe, Stephen J., Zaller, Dennis M., Doherty, James B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2226
container_issue 6
container_start_page 2222
container_title Bioorganic & medicinal chemistry letters
container_volume 18
creator Chen, Meng-Hsin
Fitzgerald, Patricia
Singh, Suresh B.
O’Neill, Edward A.
Schwartz, Cheryl D.
Thompson, Chris M.
O’Keefe, Stephen J.
Zaller, Dennis M.
Doherty, James B.
description The synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and this modification led to enhanced p38α inhibitory activity. From a study of C-7 substituents with amino acid side chains, a very potent series of compounds in the p38α enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity was improved in this latter series of compounds by judicious modification of the physical properties in appropriate regions of the lead. Synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and lead to enhanced p38 inhibitory activity. From a study of C-7 substitutions by amino acid side chains, a very potent series of compounds in the p38 enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity can be improved in this series of compounds by judicious modification of the physical properties at appropriate regions of the lead.
doi_str_mv 10.1016/j.bmcl.2006.10.097
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70408166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X06012959</els_id><sourcerecordid>70408166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-ee7e69dc957f3b1913615b7057f18f6099008ac812d576072d510359c8ca7b523</originalsourceid><addsrcrecordid>eNp9kE2LFDEQhoMo7uzqH_AgfdFbj1Xd6XyAl2XRVVhRUMFbSKfTTo09yZj0LMy_N-0M6slDUdTLU0XxMPYMYY2A4tV23e_ctG4ARAnWoOUDtkIueN1y6B6yFWgBtdL82wW7zHkLgBw4f8wuULUoUMkVs5-PYd74TLmyYah6ilP8Ts5OlXUz3dN8rOJY_TxQiFOp4H9jA22OQ4r_xvtWVR-uP1U_KNjsKwob6mmOKT9hj0Y7Zf_03K_Y17dvvty8q-8-3r6_ub6rXav4XHsvvdCD050c2x41tgK7XkIZUY0CtAZQ1ilshk4KkKUhtJ12ylnZd017xV6e7u6Xx3yezY6y89Nkg4-HbCRwUChEAZsT6FLMOfnR7BPtbDoaBLOINVuziDWL2CUrYsvS8_P1Q7_zw9-Vs8kCvDgDNhd9Y7LBUf7DNdCgbKQu3OsT54uLe_LJZEc-OD9Q8m42Q6T__fELjDCWvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70408166</pqid></control><display><type>article</type><title>Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chen, Meng-Hsin ; Fitzgerald, Patricia ; Singh, Suresh B. ; O’Neill, Edward A. ; Schwartz, Cheryl D. ; Thompson, Chris M. ; O’Keefe, Stephen J. ; Zaller, Dennis M. ; Doherty, James B.</creator><creatorcontrib>Chen, Meng-Hsin ; Fitzgerald, Patricia ; Singh, Suresh B. ; O’Neill, Edward A. ; Schwartz, Cheryl D. ; Thompson, Chris M. ; O’Keefe, Stephen J. ; Zaller, Dennis M. ; Doherty, James B.</creatorcontrib><description>The synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and this modification led to enhanced p38α inhibitory activity. From a study of C-7 substituents with amino acid side chains, a very potent series of compounds in the p38α enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity was improved in this latter series of compounds by judicious modification of the physical properties in appropriate regions of the lead. Synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and lead to enhanced p38 inhibitory activity. From a study of C-7 substitutions by amino acid side chains, a very potent series of compounds in the p38 enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity can be improved in this series of compounds by judicious modification of the physical properties at appropriate regions of the lead.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2006.10.097</identifier><identifier>PMID: 18316187</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Crystallography, X-Ray ; Cyclization ; Humans ; MAP Kinase inhibitors ; Medical sciences ; Molecular Structure ; p38 ; p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors ; p38 Mitogen-Activated Protein Kinases - metabolism ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - chemical synthesis ; Protein Kinase Inhibitors - pharmacology ; Pyridazines - chemistry ; Pyrimidines - chemistry ; Quinolones - chemical synthesis ; Quinolones - chemistry ; Quinolones - pharmacology</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2008-03, Vol.18 (6), p.2222-2226</ispartof><rights>2006 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-ee7e69dc957f3b1913615b7057f18f6099008ac812d576072d510359c8ca7b523</citedby><cites>FETCH-LOGICAL-c384t-ee7e69dc957f3b1913615b7057f18f6099008ac812d576072d510359c8ca7b523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X06012959$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20217279$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18316187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Meng-Hsin</creatorcontrib><creatorcontrib>Fitzgerald, Patricia</creatorcontrib><creatorcontrib>Singh, Suresh B.</creatorcontrib><creatorcontrib>O’Neill, Edward A.</creatorcontrib><creatorcontrib>Schwartz, Cheryl D.</creatorcontrib><creatorcontrib>Thompson, Chris M.</creatorcontrib><creatorcontrib>O’Keefe, Stephen J.</creatorcontrib><creatorcontrib>Zaller, Dennis M.</creatorcontrib><creatorcontrib>Doherty, James B.</creatorcontrib><title>Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and this modification led to enhanced p38α inhibitory activity. From a study of C-7 substituents with amino acid side chains, a very potent series of compounds in the p38α enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity was improved in this latter series of compounds by judicious modification of the physical properties in appropriate regions of the lead. Synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and lead to enhanced p38 inhibitory activity. From a study of C-7 substitutions by amino acid side chains, a very potent series of compounds in the p38 enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity can be improved in this series of compounds by judicious modification of the physical properties at appropriate regions of the lead.</description><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Crystallography, X-Ray</subject><subject>Cyclization</subject><subject>Humans</subject><subject>MAP Kinase inhibitors</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>p38</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - chemical synthesis</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyridazines - chemistry</subject><subject>Pyrimidines - chemistry</subject><subject>Quinolones - chemical synthesis</subject><subject>Quinolones - chemistry</subject><subject>Quinolones - pharmacology</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE2LFDEQhoMo7uzqH_AgfdFbj1Xd6XyAl2XRVVhRUMFbSKfTTo09yZj0LMy_N-0M6slDUdTLU0XxMPYMYY2A4tV23e_ctG4ARAnWoOUDtkIueN1y6B6yFWgBtdL82wW7zHkLgBw4f8wuULUoUMkVs5-PYd74TLmyYah6ilP8Ts5OlXUz3dN8rOJY_TxQiFOp4H9jA22OQ4r_xvtWVR-uP1U_KNjsKwob6mmOKT9hj0Y7Zf_03K_Y17dvvty8q-8-3r6_ub6rXav4XHsvvdCD050c2x41tgK7XkIZUY0CtAZQ1ilshk4KkKUhtJ12ylnZd017xV6e7u6Xx3yezY6y89Nkg4-HbCRwUChEAZsT6FLMOfnR7BPtbDoaBLOINVuziDWL2CUrYsvS8_P1Q7_zw9-Vs8kCvDgDNhd9Y7LBUf7DNdCgbKQu3OsT54uLe_LJZEc-OD9Q8m42Q6T__fELjDCWvg</recordid><startdate>20080315</startdate><enddate>20080315</enddate><creator>Chen, Meng-Hsin</creator><creator>Fitzgerald, Patricia</creator><creator>Singh, Suresh B.</creator><creator>O’Neill, Edward A.</creator><creator>Schwartz, Cheryl D.</creator><creator>Thompson, Chris M.</creator><creator>O’Keefe, Stephen J.</creator><creator>Zaller, Dennis M.</creator><creator>Doherty, James B.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080315</creationdate><title>Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors</title><author>Chen, Meng-Hsin ; Fitzgerald, Patricia ; Singh, Suresh B. ; O’Neill, Edward A. ; Schwartz, Cheryl D. ; Thompson, Chris M. ; O’Keefe, Stephen J. ; Zaller, Dennis M. ; Doherty, James B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-ee7e69dc957f3b1913615b7057f18f6099008ac812d576072d510359c8ca7b523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Crystallography, X-Ray</topic><topic>Cyclization</topic><topic>Humans</topic><topic>MAP Kinase inhibitors</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>p38</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - chemical synthesis</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyridazines - chemistry</topic><topic>Pyrimidines - chemistry</topic><topic>Quinolones - chemical synthesis</topic><topic>Quinolones - chemistry</topic><topic>Quinolones - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Meng-Hsin</creatorcontrib><creatorcontrib>Fitzgerald, Patricia</creatorcontrib><creatorcontrib>Singh, Suresh B.</creatorcontrib><creatorcontrib>O’Neill, Edward A.</creatorcontrib><creatorcontrib>Schwartz, Cheryl D.</creatorcontrib><creatorcontrib>Thompson, Chris M.</creatorcontrib><creatorcontrib>O’Keefe, Stephen J.</creatorcontrib><creatorcontrib>Zaller, Dennis M.</creatorcontrib><creatorcontrib>Doherty, James B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Meng-Hsin</au><au>Fitzgerald, Patricia</au><au>Singh, Suresh B.</au><au>O’Neill, Edward A.</au><au>Schwartz, Cheryl D.</au><au>Thompson, Chris M.</au><au>O’Keefe, Stephen J.</au><au>Zaller, Dennis M.</au><au>Doherty, James B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2008-03-15</date><risdate>2008</risdate><volume>18</volume><issue>6</issue><spage>2222</spage><epage>2226</epage><pages>2222-2226</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and this modification led to enhanced p38α inhibitory activity. From a study of C-7 substituents with amino acid side chains, a very potent series of compounds in the p38α enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity was improved in this latter series of compounds by judicious modification of the physical properties in appropriate regions of the lead. Synthesis and biological activities of some quinolinone and dihydroquinolinone p38 MAP kinase inhibitors are reported. Modifications to the dihydroquinolinone pharmacophore revealed that dihydroquinolinone may be replaced with a quinolinone pharmacophore and lead to enhanced p38 inhibitory activity. From a study of C-7 substitutions by amino acid side chains, a very potent series of compounds in the p38 enzyme assays was identified. Translation of the in vitro activity into reasonable whole blood activity can be improved in this series of compounds by judicious modification of the physical properties at appropriate regions of the lead.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18316187</pmid><doi>10.1016/j.bmcl.2006.10.097</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2008-03, Vol.18 (6), p.2222-2226
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_70408166
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Crystallography, X-Ray
Cyclization
Humans
MAP Kinase inhibitors
Medical sciences
Molecular Structure
p38
p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors
p38 Mitogen-Activated Protein Kinases - metabolism
Pharmacology. Drug treatments
Protein Kinase Inhibitors - chemical synthesis
Protein Kinase Inhibitors - pharmacology
Pyridazines - chemistry
Pyrimidines - chemistry
Quinolones - chemical synthesis
Quinolones - chemistry
Quinolones - pharmacology
title Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T01%3A13%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20biological%20activity%20of%20quinolinone%20and%20dihydroquinolinone%20p38%20MAP%20kinase%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Chen,%20Meng-Hsin&rft.date=2008-03-15&rft.volume=18&rft.issue=6&rft.spage=2222&rft.epage=2226&rft.pages=2222-2226&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2006.10.097&rft_dat=%3Cproquest_cross%3E70408166%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70408166&rft_id=info:pmid/18316187&rft_els_id=S0960894X06012959&rfr_iscdi=true